Market Overview

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Mednax, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Share:

The securities litigation law firm of Brower Piven, A Professional
Corporation, announces that a class action lawsuit has been commenced in
the United States District Court for the Southern District of Florida on
behalf of purchasers of Mednax, Inc. (NYSE:MD) ("Mednax" or the
"Company") securities during the period between February 4, 2016 to July
27, 2017, inclusive (the "Class Period"). Investors who wish to become
proactively involved in the litigation have until September 10, 2018 to
seek appointment as lead plaintiff.

If you wish to choose counsel to represent you and the class, you must
apply to be appointed lead plaintiff and be selected by the Court. The
lead plaintiff will direct the litigation and participate in important
decisions including whether to accept a settlement for the class in the
action. The lead plaintiff will be selected from among applicants
claiming the largest loss from investment in Mednax securities during
the Class Period. Members of the class will be represented by the lead
plaintiff and counsel chosen by the lead plaintiff. No class has yet
been certified in the above action.

The complaint accuses the defendants of violations of the Securities
Exchange Act of 1934 by virtue of the defendants' failure to disclose
during the Class Period that Mednax's business model was not sustainable
and its growth was based upon suppressing physician compensation and
enforcing non-compete agreements to deter physician defections.

According to the complaint, following a July 28, 2017 announcement that
the Company had not acquired any anesthesiology practice groups for that
quarter and that the chance of it acquiring any more was remote, the
value of Mednax shares declined significantly.

If you have suffered a loss in excess of $100,000 from investment in
Mednax securities purchased on or after February 4, 2016 and held
through the revelation of negative information during and/or at the end
of the Class Period and would like to learn more about this lawsuit and
your ability to participate as a lead plaintiff, without cost or
obligation to you, please contact Brower Piven either by email at hoffman@browerpiven.com
or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating
securities and other class action cases and have been advocating for the
rights of shareholders since the 1980s. If you choose to retain counsel,
you may retain Brower Piven without financial obligation or cost to you,
or you may retain other counsel of your choice. You need take no action
at this time to be a member of the class.

View Comments and Join the Discussion!